A new development on Andromeda’s Minotaur takeover was released today…
The post Andromeda (ASX:ADN) share price rocketed 14% today. Here’s why appeared first on The Motley Fool Australia. –
Key points
The Andromeda share price surged 13.95% today
Andromeda’s takeover offer for Minotaur was “overwhelmingly” accepted
Only a few conditions remain before takeover at the end of January
The Andromeda Metals Ltd (ASX: ADN) share price is in the news again today following an update on its takeover offer for Minotaur Exploration Ltd (ASX: MEP).
At market close, the Andromeda share price was up 13.95% trading at 24 cents apiece, and the Minotaur share price was up 12.5% trading at 27 cents.
Andomeda’s takeover decision
Today, Andromeda announced that Minotaur shareholders had approved the proposed demerger of its copper and gold assets into its subsidiary Demetallica at its general meeting today.
This means all non-kaolin related assets, including copper, gold and other projects in Queensland and South Australia, will be moved under the umbrella of Demetallica.
Demetallica will then push for an initial public offering (IPO) and apply for ASX listing in April.
The demerger was one of the major conditions of Andromeda’s takeover offer, and leaves just a few other conditions to be addressed before finalising on 7pm 31 January, unless extended or withdrawn.
This includes a including a minimum 90% acceptance of the offer, no “material adverse advent” or “prescribed occurrences”.
The demerger, which was a condition of the takeover offer, was made today at the Minotaur general meeting.
Last days for Minotaur Exploration
Just yesterday, Minotaur released its cash flow and activities update for the quarter ending 31 December, reporting it had $5.61 billion available in funding for future operating activities — a potential draw for Andromeda investors.
Today, Minotaur non-executive chair Roger Higgins addressed shareholders for potentially the last time. He said:
If the demerger resolutions are carried today Minotaur will inevitably become a subsidiary of Andromeda Metals Ltd (ASX: ADN) and, in due course, very likely be removed from the ASX list.
But not everyone will be seeing these new changes for the companies — today, Andromeda chair and non-executive director Rhoderick Grivas announced his resignation due to “family reasons”.
Andromeda share price snapshot
The Andromeda share price dropped by almost 20% in the past 12 months. It hit its 52-week-low of 14 cents in mid September, just before announcing positive HPA test results from its Canadian facility.
The company has a market capitalisation of $534 million and 2.48 billion shares outstanding.
The post Andromeda (ASX:ADN) share price rocketed 14% today. Here’s why appeared first on The Motley Fool Australia.
Should you invest $1,000 in Andromeda right now?
Before you consider Andromeda, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Andromeda wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of January 13th 2022
More reading
Minotaur Resources (ASX:MEP) share price spikes on Andromeda, quarterly update
Why is the Andromeda Metals (ASX:ADN) share price leaping another 18% today?
Why has the Andromeda (ASX:ADN) share price rocketed 26% in a month?
Motley Fool contributor Alice de Bruin has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
